Zerodol P

What Is Zerodol P?

Zerodol P is a fixed‑dose combination tablet that contains aceclofenac 100 mg (a non‑steroidal anti‑inflammatory drug, NSAID) and paracetamol 325 mg (an analgesic and antipyretic). The two agents work together to relieve pain, reduce inflammation, and lower fever.

• Aceclofenac inhibits cyclo‑oxygenase‑1 and cyclo‑oxygenase‑2 enzymes, decreasing prostaglandin synthesis. This reduces inflammation, swelling, and pain at the site of injury.
• Paracetamol acts centrally to block the conversion of prostaglandin H₂ to prostaglandin E₂ in the brain, providing analgesia and antipyresis without significant peripheral anti‑inflammatory activity.

The combination allows lower doses of each component while achieving synergistic pain relief, which can lessen the gastrointestinal (GI) side‑effects often seen with higher‑dose NSAIDs alone.

Approved Indications

• Acute musculoskeletal pain (sprains, strains, back pain)
• Osteoarthritis and rheumatoid arthritis flares
• Dental pain and postoperative dental inflammation
• Dysmenorrhea (menstrual cramps)
• Fever associated with viral or bacterial infections

Dosage & Administration

Patient	Recommended Dose	Frequency	Maximum Daily Dose
Adults (≥18 y)	1 tablet (100 mg aceclofenac + 325 mg paracetamol)	Every 8 hours	3 tablets (300 mg aceclofenac + 975 mg paracetamol)
Elderly or mild hepatic/renal impairment	Same as adults, but monitor closely	Every 8 hours	Same limit; consider dose reduction if renal function <30 mL/min
Children	Not recommended (paracetamol dose may be inadequate)	–	–

• With or without food – taking with food can reduce GI irritation.
• Duration – typically 5–7 days for acute pain; longer only under physician supervision.

Safety Profile

Major Warnings (no black‑box warning)

• Gastrointestinal risk – NSAIDs can cause ulceration, bleeding, or perforation, especially with prolonged use, a history of peptic ulcer disease, or concomitant corticosteroids/anticoagulants.
• Cardiovascular risk – NSAIDs may increase the risk of thrombotic events (myocardial infarction, stroke). Use the lowest effective dose for the shortest duration.
• Renal impairment – can reduce renal blood flow; monitor serum creatinine in patients with existing kidney disease.
• Hepatotoxicity – rare but possible; avoid in severe liver disease.

Contraindications

• Known hypersensitivity to aceclofenac, other NSAIDs, or paracetamol.
• Active or history of GI ulcer/bleeding.
• Severe heart failure, uncontrolled hypertension, or recent myocardial infarction.
• Severe hepatic or renal impairment.
• Third‑trimester pregnancy (NSAIDs are contraindicated).

Common Adverse Effects

• Dyspepsia, nausea, abdominal pain
• Headache, dizziness
• Mild elevation of liver enzymes
• Skin rash or pruritus (rare)

Drug Interactions of Note

• Anticoagulants (warfarin, DOACs) – increased bleeding risk.
• Other NSAIDs or corticosteroids – additive GI toxicity.
• Lithium – NSAIDs may raise lithium levels; monitor serum lithium.
• Methotrexate – NSAIDs can reduce renal clearance, raising methotrexate toxicity.
• Alcohol – potentiates hepatotoxicity of paracetamol.

—

Practical Use in Dental Practice

• Post‑extraction pain – a single tablet every 8 hours provides effective analgesia while minimizing the need for higher‑dose opioids.
• Acute periapical abscess – adjunct to definitive endodontic therapy; reduces inflammation and improves patient comfort.
• Temporomandibular joint (TMJ) flare‑ups – NSAID component helps control joint inflammation; paracetamol adds analgesia without increasing NSAID dose.

Tips for Prescribing

1. Verify no active GI ulcer or recent cardiovascular event before initiating therapy.
2. Counsel patients to avoid alcohol while on the medication.
3. Advise taking the tablet with a light snack if GI upset occurs.
4. Review all concurrent medications for potential interactions, especially anticoagulants.

Quick Reference

• Indication: Acute pain, inflammation, fever (adult)
• Dose: 1 tablet q8h, max 3 tablets/24 h
• Take: With or without food; consider food for GI comfort
• Key Contra‑indications: Active ulcer, severe heart failure, third‑trimester pregnancy
• Major Interaction: Warfarin – monitor INR closely
• When to stop: GI bleeding, severe rash, hepatic dysfunction

Clinical Pearls

• Combine with a proton‑pump inhibitor (e.g., omeprazole) in patients with a history of ulcer disease to mitigate GI risk.
• Use the lowest effective dose for the shortest period; many dental patients achieve adequate pain control with just 2–3 days of therapy.
• Check renal function before prescribing to elderly patients; a modest dose reduction can prevent acute kidney injury.
• Avoid in patients on high‑dose aspirin (≥325 mg) because the additive antiplatelet effect raises bleeding risk.
• Educate about alcohol – even moderate intake can tip paracetamol toward hepatotoxicity when combined with NSAID‑related renal stress.

FAQ